Nimesh Patel: Understanding Plasmapheresis – A Clinical Overview
Nimesh Patel, National Board Of Examinations in Medical Sciences at CKS Hospitals, shared a post on LinkedIn:
“Understanding Plasmapheresis: A Clinical Overview
Plasmapheresis—also known as therapeutic plasma exchange (TPE)—is a critical procedure used to remove large molecules such as pathogenic autoantibodies, immune complexes, or toxins from a patient’s plasma.
When the removal of circulating substances is required to halt or reverse disease progression, TPE becomes an essential intervention.
Key Clinical Indications
- Neurology: Myasthenia gravis, Guillain-Barré syndrome, and Chronic inflammatory demyelinating polyneuropathy (CIDP).
- Hematology: Thrombotic thrombocytopenic purpura (TTP) and Hyperviscosity syndrome.
- Nephrology: Anti-GBM disease (Goodpasture syndrome) and ANCA-associated vasculitis.
- Immunology and Other: Transplant rejection (ABO-incompatible) and Catastrophic antiphospholipid syndrome.
Potential Complications
While generally well-tolerated, the extracorporeal circuit and plasma replacement process carry inherent risks.
- Hypocalcemia: Commonly caused by citrate toxicity used for anticoagulation, which can lead to tingling, muscle cramps, or cardiac arrhythmias.
- Hypotension: Often related to volume shifts or patient sensitivity to the procedure.
- Infection/Access-related: Risks such as bacteremia or thrombosis associated with central venous catheter placement.
- Coagulopathy: Increased bleeding risk resulting from the removal of clotting factors.
- Allergic Reactions: Sensitivity to replacement fluids (e.g., albumin or fresh frozen plasma), ranging from mild urticaria to anaphylaxis.
Educational Disclaimer:
This content is intended for educational purposes only. Clinical decisions should always be individualized based on patient condition, clinical judgment, and institutional protocols.”

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026